Literature DB >> 35819576

The effect of mTOR activation and PTEN inhibition on human primordial follicle activation in ovarian tissue culture.

Zeinab Ghezelayagh1,2, Naeimeh Sadat Abtahi2, Mojtaba Rezazadeh Valojerdi3, Bita Ebrahimi4.   

Abstract

PURPOSE: The effect of PTEN inhibitor (Bpv(HOpic); Bpv) and mTOR activators (phosphatidic acid (PA) and propranolol (PP)), were evaluated on the activation and subsequent development of human primordial follicles in ovarian tissue culture.
METHODS: Slow frozen-thawed human ovarian cortical strips were incubated for 24 h in different groups: (1) Control (base medium), (2) Bpv (100 µM), (3) PA (200 µM), (4) PA + PP (50 µm), and (5) Bpv + PA + PP. Afterward, the medium was exchanged, and all groups were cultured without stimulators for 6 additional days. The proportion of normal and degenerated follicles, estradiol secretion, and expression of RPS6, FOXO3a, and AKT proteins was evaluated and compared between groups.
RESULTS: After 24 h of culture, there was no significant difference between the proportion of primordial and growing follicles in either of the experimental groups. This non-significant change was also observed for the phosphorylated protein to total protein ratios of RPS6, FOXO3a, and AKT proteins. After 7 days of culture, the proportion of the transitional follicles was significantly higher in comparison to the primordial follicles for the PA, PA + PP, and Bpv + PA + PP groups. The estradiol level was significantly higher on the last day compared to the first day, in PA, PA + PP, and Bpv + PA + PP groups. Hormonal secretion was significantly higher in the PA and PA + PP groups and lower in the Bpv and Bpv + PA + PP groups compared to the control on day 7 of culture.
CONCLUSION: Temporary in vitro treatment of human ovarian tissue with mTOR activators enhances the initiation of primordial follicle development and positively influences steroidogenesis after short-term culture.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Human ovarian tissue; In vitro activation; PI3K pathway; Primordial follicle; mTOR pathway

Mesh:

Substances:

Year:  2022        PMID: 35819576      PMCID: PMC9428071          DOI: 10.1007/s10815-022-02537-6

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.357


  23 in total

1.  Growth differentiating factor 9 (GDF9) and bone morphogenetic protein 15 both activate development of human primordial follicles in vitro, with seemingly more beneficial effects of GDF9.

Authors:  Alon Kedem; Benjamin Fisch; Roni Garor; Adi Ben-Zaken; Taya Gizunterman; Carmela Felz; Avi Ben-Haroush; Dragan Kravarusic; Ronit Abir
Journal:  J Clin Endocrinol Metab       Date:  2011-06-01       Impact factor: 5.958

2.  Specificity of the requirement for Foxo3 in primordial follicle activation.

Authors:  George B John; Lane J Shirley; Teresa D Gallardo; Diego H Castrillon
Journal:  Reproduction       Date:  2007-05       Impact factor: 3.906

3.  Activation of dormant ovarian follicles to generate mature eggs.

Authors:  Jing Li; Kazuhiro Kawamura; Yuan Cheng; Shuang Liu; Cynthia Klein; Shu Liu; En-Kui Duan; Aaron J W Hsueh
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

4.  Role of the PI3K and Hippo pathways in follicle activation after grafting of human ovarian tissue.

Authors:  Rossella Masciangelo; Camille Hossay; Maria Costanza Chiti; Diego Daniel Manavella; Christiani Andrade Amorim; Jacques Donnez; Marie-Madeleine Dolmans
Journal:  J Assist Reprod Genet       Date:  2019-11-15       Impact factor: 3.412

5.  The combination of basic fibroblast growth factor and kit ligand promotes the proliferation, activity and steroidogenesis of granulosa cells during human ovarian cortical culture.

Authors:  Zeinab Ghezelayagh; Naeimeh Sadat Abtahi; Mojtaba Rezazadeh Valojerdi; Aboulfazl Mehdizadeh; Bita Ebrahimi
Journal:  Cryobiology       Date:  2020-08-29       Impact factor: 2.487

6.  Attempted application of bioengineered/biosynthetic supporting matrices with phosphatidylinositol-trisphosphate-enhancing substances to organ culture of human primordial follicles.

Authors:  Galit Lerer-Serfaty; Nivin Samara; Benjamin Fisch; Michal Shachar; Olga Kossover; Dror Seliktar; Avi Ben-Haroush; Ronit Abir
Journal:  J Assist Reprod Genet       Date:  2013-08-11       Impact factor: 3.412

7.  Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment.

Authors:  Kazuhiro Kawamura; Yuan Cheng; Nao Suzuki; Masashi Deguchi; Yorino Sato; Seido Takae; Chi-hong Ho; Nanami Kawamura; Midori Tamura; Shu Hashimoto; Yodo Sugishita; Yoshiharu Morimoto; Yoshihiko Hosoi; Nobuhito Yoshioka; Bunpei Ishizuka; Aaron J Hsueh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

Review 8.  PTEN, more than the AKT pathway.

Authors:  Carmen Blanco-Aparicio; Oliver Renner; Juan F M Leal; Amancio Carnero
Journal:  Carcinogenesis       Date:  2007-03-06       Impact factor: 4.944

9.  Short-Term PTEN Inhibition Improves In Vitro Activation of Primordial Follicles, Preserves Follicular Viability, and Restores AMH Levels in Cryopreserved Ovarian Tissue From Cancer Patients.

Authors:  Edurne Novella-Maestre; Sonia Herraiz; Beatriz Rodríguez-Iglesias; César Díaz-García; Antonio Pellicer
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

10.  Inhibition of phosphatase and tensin homologue (PTEN) in human ovary in vitro results in increased activation of primordial follicles but compromises development of growing follicles.

Authors:  Marie McLaughlin; Hazel L Kinnell; Richard A Anderson; Evelyn E Telfer
Journal:  Mol Hum Reprod       Date:  2014-05-15       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.